Skip to content

A Randomised, Placebo-Controlled, Crossover Study Investigating the Optimal Timing of a Caffeine-Containing Supplement for Exercise Performance.

PMID 32232597 (2020): caffeine, beta-alanine — Time-trial performance, Time to exhaustion (study note for endurance athletes).

Last updated/Feb 23, 2026, 10:34 PM

Study note • PMID 32232597

A Randomised, Placebo-Controlled, Crossover Study Investigating the Optimal Timing of a Caffeine-Containing Supplement for Exercise Performance.

Sports medicine - open2020 • DOI 10.1186/s40798-020-00246-x
Evidence C63/100
Action 2: Consider

Worth trying if it fits your goal and context.

ELI5

In plain language

BACKGROUND: Pre-exercise supplements containing low doses of caffeine improve endurance exercise performance, but the most efficacious time for consumption before intense endurance exercise remains unclear, as does the contribution… (randomized trial; cyclists).

The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: BACKGROUND: Pre-exercise supplements containing low doses of caffeine improve endurance exercise performance, but the most efficacious time for consumption before intense endurance exercise remains unclear, as does the contribution…
  • The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions.
  • Population: cyclists.
  • Protocol cues (title/abstract): 200 mg • 1600 mg • 1000 mg • 30 min • 35 min.

Protocol

Protocol (as reported)

  • Intervention/exposure: caffeine, beta-alanine (vs placebo).
  • Dose/time/duration cues in abstract/title: 200 mg • 1600 mg • 1000 mg • 30 min • 35 min.
  • Outcomes: Time-trial performance, Time to exhaustion.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it helps, and who should skip it

Who it helps

  • Athletes similar to the study population (cyclists) working on supplements.
  • Athletes who can measure Time-trial performance, Time to exhaustion with a repeatable workout or time-trial effort.

Who should skip

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: randomized trial (placebo-controlled).
  • Population: cyclists.
  • Comparator: placebo.
  • Outcomes measured: Time-trial performance, Time to exhaustion.
  • Protocol cues mentioned: 200 mg • 1600 mg • 1000 mg • 30 min • 35 min.
  • Source: PubMed PMID 32232597 (2020) — Sports medicine - open.

Results excerpt

What the abstract reports

Total work performed during the time trial in PRE was 5% greater than PLA (3.53 +/- 0.14 vs.

Note: excerpts are short; for full context, read the paper.

Limits

Limitations & bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Coaching beta

Get a plan that adapts to your life.

Join the 26weeks.ai TestFlight beta for adaptive coaching, recovery-aware adjustments, and race-week reminders.

Keep going

Sources